Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

New solution for cancer therapy from Siemens

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Medical Device Innovation and Regulatory Strategy...

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Technology Trends Transform Pharmaceutical Manufacturing

Deep analysis of the shift toward automated, digital, and resilient production environments. The industry is currently witnessing a massive overhaul in how life-saving medications are developed and distributed, focusing heavily on smart factory integration and strict adherence to global regulatory standards.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

One of Siemens Healthcare’s highlights of this year's Conference of the European Society for Therapeutic Radiology and Oncology (ESTRO) is IM-RealART™ Solution for adaptive radiotherapy. With IM-RealART, treatment plans for radiotherapy can be adapted especially fast to changes in the shape and position of tumors. The treatment plan is revised even while the patient is still lying on the treatment table. This means that the radiation fields and dose are recalculated directly before the next fraction is irradiated.

With IM-RealART, Siemens Healthcare offers a new solution for especially fast replanning of treatment plans in adaptive radiotherapy. The solution includes the Siemens products Artiste™ Solution (linear accelerator), the 550TxT™ treatment table, the CTVision™ System for diagnostic CT (computed tomography) imaging and the RealART™ planning system from Prowess Inc.

One of the special advantages of IM-RealART is CTVision. Using this system, top quality "gold standard" images of tumors can be taken directly in the treatment room using a CT scanner running on rails. While the patient lies immobilized on the treatment table, the current scans are compared to the original ones on which the treatment planning was based and evaluated.

If the shape of the tumor has changed, the treatment plan can be adapted immediately in order to correct the shape of the treatment radiation field as well as the dose. This recalculation is usually performed in just seven minutes. Since the patient's position is not changed during this period, it is possible to irradiate the tumor with high precision. Using the 160MLC™ multileaf collimator from Siemens, the radiation field can be confined to the tumor very precisely, thus saving the surrounding tissue.

IM-RealART can be combined with the Siemens solution IM-Confident™ Plan, which consists of Artiste with the 160MLC and an intelligent irradiation planning software. These components help reduce the treatment time required for intensity-modulated radiation therapy (IMRT) to five minutes or even less.

IM-RealART and IM-Confident from Siemens offer two solutions which, on the one hand, make daily workflows in radiooncology much simpler and more efficient while, at the same time, enabling high precision patient treatment: Using innovative technologies, the tumor is irradiated with pinpoint accuracy while the latest software and imaging ensure that planning, replanning and therapy all proceed as swiftly as possible. This corresponds to Siemens' philosophy for radiotherapy: To achieve rapid and precise treatment while sparing the patient undue discomfort.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector
posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare .

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Medical Device Innovation and Regulatory Strategy Trends

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Technology Trends Transform Pharmaceutical Manufacturing

Deep analysis of the shift toward automated, digital, and resilient production environments. The industry is currently witnessing a massive overhaul in how life-saving medications are developed and distributed, focusing heavily on smart factory integration and strict adherence to global regulatory standards.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Regulatory Trends Shaping Medical Technology

The path from innovation to clinical implementation is governed by an increasingly complex and dynamic set of global standards. As digital health and artificial intelligence become integral to patient care, the frameworks that ensure safety and efficacy are evolving to address the unique challenges of software-based medical solutions and interconnected hardware.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »